Conference Event Schedule

AACC (American Association For Clinical Chemistry)

Meeting Dates: September 27-30, 2021

Please join Kova International, Inc. and Biochemical Diagnostics, Inc. at the AACC (American Association for Clinical Chemistry) at the Georgia World Congress Center

Booth 706, where we will be showcasing our latest offerings and technologies and will have our top product experts on hand to answer your questions

SOFT (Society of Forensic Toxicologists) Annual Meeting 2021

September 26-October 1, 2021, Nashville Tennessee

Due to the conflict with AACC, we will not have a booth at SOFT this year but look forward to seeing everyone at DATIA or next year at SOFT


November 15-18, 2021 - Dusseldorf, Germany

We are exhibiting at MEDICA 2021, World Forum for Medicine and hope to see you there! You are invited to join Kova International, Inc. and Biochemical Diagnostics, Inc., November 15th – 18th in Dusseldorf, Germany. Meet with our product experts who will be there to answer questions on our latest offerings and technologies.

DATIA (Drug and Alcohol Testing Industry Association)

August 25-27, 2021 - Washington D.C: New Date

I will be attending DATIA and look forward to meeting our customers for a drink and a sit down to discuss our newest products.



Posted on : June 06, 2016

GARDEN GROVE, CA, JUNE 3, 2016 – Kova International, Inc. (“Kova”) announced today that it has acquired Biochemical Diagnostics, Inc. (“Biochemical Diagnostics”). The transaction was completed on April 22, 2016. Financial terms of the transaction were not disclosed. Founded in 1981, Biochemical Diagnostics, based in Edgewood, NY is a leading manufacturer and marketer of controls and disposable sample preparation products used in drugs of abuse testing. Biochemical Diagnostics’ products are utilized in toxicology and clinical laboratories and also in handheld devices for point of care testing. The acquisition of Biochemical Diagnostics expands Kova’s product line into the drugs of abuse testing area and provides the combined company with opportunities to cross-sell Biochemical Diagnostics’ products through Kova’s robust distribution network.

“This acquisition builds on Kova International’s 35 years of innovation and quality, supporting our strategic priorities and further expanding Kova’s product offerings and value proposition. Biochemical Diagnostics enhances the KOVA brand through its FDA/DEA approved products, recognized brand name and ISO certified manufacturing practices. Kova increases Biochemical Diagnostics’ distribution reach and diversifies its product portfolio,” said Nita Moritz, President of Kova.

Allen Panetz, the founder of Biochemical Diagnostics, who will remain with the company following the transaction, commented, “The entire Biochemical Diagnostics team is excited to be joining the Kova family knowing that the expansion of the company’s footprint to two locations, one on the East Coast and one on the West Coast will be of immense benefit to our combined customers. Kova’s resources will enable us to expand the reach of our product offering and develop new products while continuing to provide high quality controls and a robust line of sample preparation disposables and equipment to our loyal customers.”

Kova International, Inc.
  • 7272 Chapman Avenue, Suite B,
    Garden Grove, CA 92841

  • Phone: +1(714) 902-1700

  • Toll Free: +1 (855) 217-6399

  • Email: Kova International Support

Biochemical Diagnostics, Inc.
  • 180 Heartland Blvd.
    Edgewood, NY 11717

  • Phone: +1 (631) 595-9200

  • Toll Free: +1 (800)-223-4835

  • Email: BCD Support